- Home
- RDNT vs PEN Comparison
RDNT vs PEN Comparison
Compare RDNT & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDNT
- PEN
- Stock Information
- Founded
- RDNT 1985
- PEN 2004
- Country
- RDNT United States
- PEN United States
- Employees
- RDNT N/A
- PEN N/A
- Industry
- RDNT Medical Specialities
- PEN Medical/Dental Instruments
- Sector
- RDNT Health Care
- PEN Health Care
- Exchange
- RDNT Nasdaq
- PEN Nasdaq
- Market Cap
- RDNT 6.0B
- PEN 7.0B
- IPO Year
- RDNT 1986
- PEN 2015
- Fundamental
- Price
- RDNT $72.16
- PEN $243.19
- Analyst Decision
- RDNT Strong Buy
- PEN Buy
- Analyst Count
- RDNT 4
- PEN 15
- Target Price
- RDNT $84.75
- PEN $259.86
- AVG Volume (30 Days)
- RDNT 515.2K
- PEN 337.8K
- Earning Date
- RDNT 11-10-2024
- PEN 10-30-2024
- Dividend Yield
- RDNT N/A
- PEN N/A
- EPS Growth
- RDNT N/A
- PEN N/A
- EPS
- RDNT N/A
- PEN 0.89
- Revenue
- RDNT $1,772,946,000.00
- PEN $1,163,776,000.00
- Revenue This Year
- RDNT $14.93
- PEN $13.65
- Revenue Next Year
- RDNT $8.83
- PEN $14.38
- P/E Ratio
- RDNT N/A
- PEN $273.90
- Revenue Growth
- RDNT 12.20
- PEN 16.96
- 52 Week Low
- RDNT $33.44
- PEN $148.00
- 52 Week High
- RDNT $93.65
- PEN $277.34
- Technical
- Relative Strength Index (RSI)
- RDNT 34.14
- PEN 51.31
- Support Level
- RDNT $78.42
- PEN $235.76
- Resistance Level
- RDNT $79.45
- PEN $251.28
- Average True Range (ATR)
- RDNT 2.66
- PEN 7.13
- MACD
- RDNT -1.44
- PEN -1.55
- Stochastic Oscillator
- RDNT 7.20
- PEN 25.79
About RDNT RadNet Inc.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
About PEN Penumbra Inc.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.